Multi-omics analyses reveal distinct molecular characteristics and transformation mechanisms of stage I-III micropapillary lung adenocarcinoma

被引:0
|
作者
Qu, Yang [1 ]
Feng, Xiaoli [1 ]
Chen, Hanlin [2 ]
Tan, Fengwei [3 ]
Shao, Anqi [4 ]
Pang, Jiaohui [2 ]
Xue, Qi [3 ]
Zheng, Bo [1 ]
Zheng, Wei [3 ]
Ou, Qiuxiang [2 ]
Gao, Shugeng [3 ]
Shao, Kang [3 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Canc, Natl Canc Ctr, Dept Pathol,Canc Hosp, Beijing, Peoples R China
[2] Nanjing Geneseeq Technol Inc, Nanjing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Canc, Natl Canc Ctr, Dept Thorac Surg,Canc Hosp, Beijing 100021, Peoples R China
[4] Columbia Univ, Vagelos Coll Phys & Surg, Irving Med Ctr, Dept Dermatol, New York, NY USA
来源
关键词
micropapillary lung adenocarcinoma; microdissection; next-generation sequencing; RNA sequencing; transformation; recurrence-free survival; INTERNATIONAL ASSOCIATION; CLASSIFICATION; PROGNOSIS; EGFR; SURVIVAL; PATTERN;
D O I
10.1002/path.6416
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The micropapillary (MIP) pattern is a high-grade histological subtype of lung adenocarcinoma (LUAD) with poor prognosis. In this study, surgically resected tumor samples from 101 patients with stage I-III MIP-LUAD (MIP >= 30%) were microdissected to separate MIP components from non-MIP components, all of which underwent RNA and DNA whole-exome sequencing (WES). The genomic and transcriptomic landscapes of MIP and non-MIP components within MIP-enriched tumor tissues demonstrated remarkable similarities, notably marked by high epidermal growth factor receptor (EGFR) alteration frequencies. However, when compared to MIP-na & iuml;ve LUAD tissues, MIP components showed higher chromosomal instability and revealed 18 enriched alterations, encompassing EGFR mutations, EGFR amplifications, and CDKN2A/CDKN2B deletions, which all linked to upregulation of cell proliferation pathways and downregulation of immune pathways. Shared mutations were observed in 97.8% (91/93) of patients with paired DNA WES data for MIP and non-MIP components within the same tissues, suggesting a common origin. The recurrence-free survival analysis identified MACF1, PCLO, ADGRV1, and Fanconi Anemia pathway mutations as negative indicators. In all, we conducted an in-depth analysis of the molecular characteristics and transformation mechanisms of MIP-LUAD, employing microdissection techniques to investigate the genomic and transcriptomic levels within a substantial cohort, providing insights for precision medicine of this aggressive cancer subtype. (c) 2025 The Pathological Society of Great Britain and Ireland.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Multi-omics analyses of red blood cell reveal antioxidation mechanisms associated with hemolytic toxicity of gossypol
    Tang, Chaohua
    Meng, Qingshi
    Zhang, Kai
    Zhan, Tengfei
    Zhao, Qingyu
    Zhang, Sheng
    Zhang, Junmin
    ONCOTARGET, 2017, 8 (61) : 103693 - 103709
  • [22] Unraveling the relapse-associated landscape and individualized therapy in stage I lung adenocarcinoma based on immune and mitochondrial metabolism hallmarks via multi-omics analyses
    Zhan, Tao
    Wang, Luyao
    Li, Zewei
    Deng, Huijing
    Huang, Liu
    Computers in Biology and Medicine, 2025, 184
  • [23] Integrated multi-omics analyses reveal the biochemical mechanisms and phylogenetic relevance of anaerobic androgen biodegradation in the environment
    Fu-Chun Yang
    Yi-Lung Chen
    Sen-Lin Tang
    Chang-Ping Yu
    Po-Hsiang Wang
    Wael Ismail
    Chia-Hsiang Wang
    Jiun-Yan Ding
    Cheng-Yu Yang
    Chia-Ying Yang
    Yin-Ru Chiang
    The ISME Journal, 2016, 10 : 1967 - 1983
  • [24] Multi-omics analysis identifies potential mechanisms of AURKB in mediating poor outcome of lung adenocarcinoma
    Huang, Jie
    Zhang, Qianyun
    Shen, Juan
    Chen, Xueqin
    Ma, Shenglin
    AGING-US, 2021, 13 (04): : 5946 - 5966
  • [25] Integrated Analyses Reveal the Multi-Omics and Prognostic Characteristics of ATP5B in Breast Cancer
    Liu, Min
    Xu, Yuxuan
    Zhou, Yaoyao
    Lang, Ronggang
    Shi, Zhenyu
    Zhao, Jing
    Meng, Yuanyuan
    Bao, Li
    FRONTIERS IN GENETICS, 2021, 12
  • [26] Comparative analyses of multi-omics profiles reveal distinctive molecular signatures of young Asian breast cancers
    Park, Yeon Hee
    Ding, Ying
    Lee, Soo-Hyeon
    Jung, Hae Hyun
    Chung, Woosung
    Cho, Soonweng
    Kim, Jin-Ho
    Deng, Shibing
    Choi, Yoon-la
    Fernandez, Julio
    Lee, Se Kyung
    Kim, Seok Won
    Lee, Jeong Eon
    Kim, Ji-Yeon
    Ahn, Jin Seok
    Im, Young-Hyuck
    Nam, Seok Jin
    Park, Woong-Yang
    Kan, Zhengyan
    CANCER RESEARCH, 2017, 77
  • [27] Pan-cancer analyses reveal multi-omics and clinical characteristics of RIO kinase 2 in cancer
    Li, Kexin
    Zou, Jiahua
    Yan, Haizhao
    Li, Yuqing
    Li, Man-Mei
    Liu, Zhong
    FRONTIERS IN CHEMISTRY, 2022, 10
  • [28] Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma
    Zhao, Yue
    Gao, Yakun
    Xu, Xiaodong
    Zhou, Jiwu
    Wang, He
    BMC CANCER, 2021, 21 (01)
  • [29] Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma
    Yue Zhao
    Yakun Gao
    Xiaodong Xu
    Jiwu Zhou
    He Wang
    BMC Cancer, 21
  • [30] Integrated multi-omics and machine learning reveal a gefitinib resistance signature for prognosis and treatment response in lung adenocarcinoma
    Zhou, Dong
    Zheng, Zhi
    Li, Yanqi
    Zhang, Jiao
    Lu, Xiao
    Zheng, Hong
    Dai, Jigang
    IUBMB LIFE, 2025, 77 (01)